Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (491-500 of 1,032) with videos related to

Pageof 104
Sort By:
JAMA|November 17, 1993
Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington DiseaseR Babul, S Adam, B Kremer, et al.
The Journal of Cell Biology|June 12, 1998
The influence of huntingtin protein size on nuclear localization and cellular toxicityA S Hackam, R Singaraja, C L Wellington, et al.
Human Mutation|February 6, 1998
Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian populationP Julien, C Gagné, M R Murthy, et al.
Brain : a Journal of Neurology|February 20, 2009
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtinMahmoud A Pouladi, Rona K Graham, Joanna M Karasinska, et al.
Journal of Lipid Research|August 1, 1996
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriersS N Pimstone, S M Clee, S E Gagné, et al.
Lancet (London, England)|June 6, 1987
First-trimester prenatal diagnosis for Huntington's disease with DNA probesM R Hayden, J Hewitt, J J Kastelein, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Primary lipoprotein lipase deficiencyJ D Brunzell, P H Iverius, M S Scheibel, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 25, 2010
Factors associated with experiences of genetic discrimination among individuals at risk for Huntington diseaseYvonne Bombard, JoAnne Palin, Jan M Friedman, et al.
Neurobiology of Disease|August 6, 2010
Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington diseaseKun Huang, Martin H Kang, Caitlin Askew, et al.
Neurobiology of Disease|September 28, 2011
Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington diseaseSonia Franciosi, Jae K Ryu, Yaein Shim, et al.
Pageof 104

Showing results (491-500 of 1,032) with videos related to

Sort By:
Pageof 104
JAMA|November 17, 1993
Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington DiseaseR Babul, S Adam, B Kremer, et al.
The Journal of Cell Biology|June 12, 1998
The influence of huntingtin protein size on nuclear localization and cellular toxicityA S Hackam, R Singaraja, C L Wellington, et al.
Human Mutation|February 6, 1998
Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian populationP Julien, C Gagné, M R Murthy, et al.
Brain : a Journal of Neurology|February 20, 2009
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtinMahmoud A Pouladi, Rona K Graham, Joanna M Karasinska, et al.
Journal of Lipid Research|August 1, 1996
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriersS N Pimstone, S M Clee, S E Gagné, et al.
Lancet (London, England)|June 6, 1987
First-trimester prenatal diagnosis for Huntington's disease with DNA probesM R Hayden, J Hewitt, J J Kastelein, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Primary lipoprotein lipase deficiencyJ D Brunzell, P H Iverius, M S Scheibel, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 25, 2010
Factors associated with experiences of genetic discrimination among individuals at risk for Huntington diseaseYvonne Bombard, JoAnne Palin, Jan M Friedman, et al.
Neurobiology of Disease|August 6, 2010
Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington diseaseKun Huang, Martin H Kang, Caitlin Askew, et al.
Neurobiology of Disease|September 28, 2011
Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington diseaseSonia Franciosi, Jae K Ryu, Yaein Shim, et al.
Pageof 104